- Report
- January 2026
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 367 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- November 2025
- 300 Pages
Global
From €3499EUR$3,995USD£3,037GBP
- Report
- September 2025
- 200 Pages
Global
From €2619EUR$2,990USD£2,273GBP
- Report
- September 2025
- 142 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- January 2026
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- November 2025
- 181 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 349 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- November 2024
- 171 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- February 2024
- 117 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- April 2023
- 115 Pages
Global
From €4160EUR$4,750USD£3,611GBP

The Diagnostic Antibodies market is a subset of the Diagnostics industry, which focuses on the development and production of antibodies used to detect and diagnose diseases. Diagnostic antibodies are used to detect the presence of a specific antigen in a sample, such as a blood or tissue sample. These antibodies are used to diagnose a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Diagnostic antibodies are also used to monitor the progression of a disease or to measure the effectiveness of a treatment.
The Diagnostic Antibodies market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and Roche. Show Less Read more